IV and short-duration oral trials METAOD001-004 enrolled smaller groups of healthy or obese men with single doses or 1-week dosing across IV (25-400 mcg/kg) and oral (9-54 mg) routes
All presented information is based on scientific publications which can be found at the end of product description below
Because IV infusions bypass both the digestive system and the muscle absorption step, they offer the most direct pathway for nutrient delivery available outside of emergency medical settings
TB-4 The July 23, 2026 PCAC recommendation covered TB-500, not the full-length TB-4 used in GLOW
Both forms require a prescription from a licensed healthcare provider, who will assess your medical history and current health status to determine if naltrexone is appropriate for you
Rapid fat loss, particularly from the face and neck, can accelerate the appearance of skin laxity